Aptiv PLC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Aptiv PLC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	12,274	12,884	14,435	14,357	13,066	15,618	17,489	20,051	19,713	20,398
Cost of revenue	9,527	10,270	11,706	11,711	11,126	13,182	14,854	16,612	16,002	16,500
Gross profit	2,747	2,614	2,729	2,646	1,940	2,436	2,635	3,439	3,711	3,898
Research and development	800	882	1,155	1,165	1,024	1,030	1,120	1,289	1,097	1,129
Selling, general and administrative	924	952	993	1,076	976	1,075	1,138	1,436	1,465	1,673
Operating income	1,539	1,416	1,473	1,276	2,118	1,189	1,263	1,559	1,842	1,184
Interest expense	155	140	141	164	164	150	219	285	337	361
Other non-operating income	-384	-21	2	14	0	-129	-54	63	41	50
Pre-tax income	1,000	1,255	1,334	1,126	1,954	910	990	1,337	2,151	919
Income tax	167	223	250	132	49	101	121	-1,928	223	700
Income from continuing operations	834	1,021	1,067	990	1,804	590	594
Net income to minority interests	69	73	40	19	18	19	-3	28	24	19
Net income	1,257	1,355	1,067	990	1,804	590	594	2,938	1,787	165
EBITDA	2,028	1,962	2,149	1,993	2,882	1,962	2,025	2,471	2,806	2,175
EPS, basic	4.60	5.07	4.04	3.85	6.72	1.95	1.96	10.50	6.97	0.75
EPS, diluted	4.59	5.06	4.02	3.85	6.66	1.94	1.96	10.39	6.96	0.75
Shares, basic (weighted)	273	267	264	257	263	270	271	277	256	220
Shares, diluted (weighted)	274	268	265	257	271	271	271	283	257	221
Dividend per share	1.16	1.38	0.88	0.88	0.22	0.00

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	737	1,596	567	412	2,821	3,139	1,531	1,640	1,573	1,575
Short-term investments								0
Receivables	2,130	2,440	2,487	2,569	2,812	2,784	3,433	3,546	3,261	1,910
Inventory	859	1,083	1,277	1,286	1,297	2,014	2,340	2,365	2,320	1,789
Other current assets	302	521	445	504	503	499	480	696	671	627
Total current assets	5,419	5,641	4,777	5,319	7,465	8,436	7,784	8,247	7,826	8,745
Property, plant and equipment	2,325	2,804	3,179	3,309	3,301	3,294	3,495	3,785	3,698	2,872
Lease right-of-use assets			0	413	380	383	451	540	495	331
Goodwill	1,502	1,944	2,524	2,407	2,580	2,511	5,106	5,151	5,024	4,008
Intangible assets	1,148	1,219	1,380	1,186	1,091	964	2,585	2,399	2,140	1,997
Other non-current assets	280	470	521	719	694	622	740	2,862	2,842	1,816
Total assets	12,292	12,169	12,480	13,459	17,522	18,007	21,884	24,427	23,458	23,413
Accounts payable	1,820	2,227	2,334	2,463	2,571	2,953	3,150	3,151	2,870	1,623
Accrued liabilities	1,242	1,296	1,054	1,155	1,385	1,246	1,684	1,648	1,752	1,191
Deferred revenue					62	0	90	93	111	84
Short-term debt	10	17	306	393	90	8	31	9	509	23
Total current liabilities	4,148	3,540	3,694	4,054	4,046	4,207	4,865	4,808	5,131	5,037
Long-term debt	3,953	4,132	4,038	3,971	4,011	4,059	6,460	6,204	7,843	7,467
Lease liabilities			0	329	300	304	361	453	412	270
Other non-current liabilities	371	526	633	611	540	436	750	701	613	479
Total liabilities	9,529	8,652	8,810	9,448	9,422	9,446	12,790	12,583	14,373	13,914
Total debt	3,963	4,149	4,344	4,364	4,101	4,067	6,581	6,296	8,465	7,653
Paid-in capital	1,633	1,649	1,639	1,645	3,897	3,939	3,989	4,028	2,966	3,619
Retained earnings	1,980	2,118	2,511	2,890	4,550	5,077	5,608	8,162	7,002	6,227
Other comprehensive income	-1,215	-471	-694	-719	-545	-672	-791	-645	-1,174	-641
Shareholders' equity	2,401	3,299	3,459	3,819	7,905	8,347	8,809	11,548	8,796	9,207
Minority interests	362	218	211	192	195	214	189	197	197	190
Total equity	2,763	3,517	3,670	4,011	8,100	8,561	8,998	11,745	8,993	9,397
Total liabilities and equity	12,292	12,169	12,480	13,459	17,522	18,007	21,884	24,427	23,458	23,413
Shares outstanding	270	266	260	255	270	271	271	279	235	213

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	1,326	1,428	1,107	1,009	1,822	609	590	2,966	1,810	181
Depreciation and amortization	489	546	676	717	764	773	762	912	964	991
Stock-based compensation	62	62	58	66	60	87	86	115	120	139
Deferred income tax	-121	-26	-14	-33	-52	-60	-144	-2,164	-34	394
Change in receivables	-207	-287	55	-74	-243	37	-497	-112	285	-216
Change in inventory	-45	-224	-120	8	-8	-710	-258	-20	45	-241
Change in payables	35	268	62	133	186	265	137	4	-210	251
Cash from operations	1,941	1,468	1,628	1,624	1,413	1,222	1,263	1,896	2,446	2,185
Capital expenditures	-657	-698	-846	-781	-584	-611	-844	-906	-830	-656
Acquisitions	-15	-324	-1,197	-334	-49	-130	-4,310	-83	0	0
Purchases of investments							0	0	-748	0
Cash from investing	-578	-1,252	-2,048	-1,111	-626	-729	-5,182	-1,002	-507	-498
Debt repaid	0	-2	-13	-25	-39	-8
Stock issued			0	0	1,115	0	0
Share buybacks	-634	-383	-499	-420	-57	0	0	-398	-4,104	-397
Dividends paid	-317	-310	-233	-226	-56	0	0
Cash from financing	-1,081	456	-555	-649	1,613	-191	2,359	-807	-1,965	-1,442
Exchange rate effect	-23	86	-54	-3	24	-16	-24	-2	-40	35
Net change in cash		758	-1,029	-139	2,424	286	-1,584	85	-66	280
Free cash flow	1,284	770	782	843	829	611	419	990	1,616	1,529
Interest paid	144	124	134	153	154	159	190	275	286	363
Income taxes paid	253	275	283	189	106	172	194	307	249	255

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $44.79 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	19.6%	Gross profit / revenue.
Operating margin	5.3%	Operating income / revenue.
EBITDA margin	10.4%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	4.1%	Pre-tax income / revenue.
Net margin	1.2%	Net income / revenue.
FCF margin	3.7%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	7.2%	Cash from operations / revenue.
Effective tax rate	56.7%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	2.5%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	1.2%	Net income / average total assets.
Return on invested capital (ROIC)	5.9%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	8.8%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.7%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	3.6%	Capital expenditures / revenue.
D&A / revenue	5.0%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	3.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	5.3%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	9.3%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	5.0%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	13.9%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	15.0%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-35.7%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-2.1%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-11.0%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-22.5%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	2.4%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-5.5%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-90.8%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-34.8%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-38.0%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-89.2%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-27.4%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-35.4%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-10.7%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	20.0%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	9.1%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-5.4%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	54.0%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	13.0%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	4.7%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	1.5%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	3.1%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-0.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	2.3%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	6.0%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-14.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-6.6%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-4.0%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.02x	Current assets / current liabilities.
Quick ratio	1.07x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.26x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.61x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	29.8%	Total debt / total assets.
Liabilities / assets	51.4%	Total liabilities / total assets.
Net debt	$4.59B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	2.37x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	$3.03B	Current assets - current liabilities.
Goodwill and intangibles / assets	32.3%	(Goodwill + intangible assets) / total assets.
Tangible book value	$2.94B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.04x	Revenue / average total assets.
Fixed asset turnover	6.79x	Revenue / average property, plant and equipment.
Inventory turnover	7.38x	Cost of revenue / average inventory.
Days inventory	49 days	365 x average inventory / cost of revenue.
Receivables turnover	7.69x	Revenue / average receivables.
Days sales outstanding	47 days	365 x average receivables / revenue.
Days payables	46 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	51 days	Days inventory + days sales outstanding - days payables.
FCF conversion	310.9%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	49.4%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$1.06	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$88.28	Revenue / diluted weighted shares.
FCF per share	$3.22	Free cash flow / diluted weighted shares.
Operating cash flow per share	$6.37	Cash from operations / diluted weighted shares.
Book value per share	$42.01	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$14.11	Tangible book value / shares outstanding.
Cash per share	$3.65	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	105.1%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$9.30B	Share price x shares outstanding.
Enterprise value	$13.89B	Market cap + total debt - cash - short-term investments.
P/E	42.3x	Market cap / net income. Only when net income is positive.
P/S	0.50x	Market cap / revenue.
P/B	1.06x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	3.16x	Market cap / tangible book value, when positive.
P/FCF	13.6x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	6.88x	Market cap / cash from operations, when positive.
EV/Sales	0.74x	Enterprise value / revenue.
EV/EBIT	14.0x	Enterprise value / operating income, when both are positive.
EV/EBITDA	7.16x	Enterprise value / EBITDA, when both are positive.
EV/FCF	20.3x	Enterprise value / free cash flow, when both are positive.
FCF yield	7.4%	Free cash flow / market cap.
Earnings yield	2.4%	Net income / market cap (the inverse of P/E).
Shareholder yield	7.7%	(Dividends paid + share buybacks) / market cap.

What was Aptiv PLC's revenue in fiscal 2025?

Aptiv PLC reported revenue of $20.40B for fiscal 2025, 3.5% higher than the year before.

Was Aptiv PLC profitable in fiscal 2025?

Yes. Net income was $165.0M, a net margin of 0.8%.

How much free cash flow did Aptiv PLC generate in fiscal 2025?

Cash from operations of $2.19B minus capital expenditures of $656.0M left free cash flow of $1.53B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Aptiv PLC